Jay S. Duker - 23 Mar 2026 Form 4 Insider Report for EyePoint, Inc. (EYPT)

Reporting relationship: President and CEO, Director
Issuer ticker: EYPT
Reported as of: 23 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Mar 2026, 16:05:54 UTC
Prior SEC filing: 16 Mar 2026
Next SEC filing: 14 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Ron Honig, Attorney-in-Fact

Key filing fact

Jay S. Duker filed Form 4 for EyePoint, Inc. (EYPT) on 24 Mar 2026.

Key facts

This page summarizes Jay S. Duker's Form 4 filing for EyePoint, Inc. (EYPT).
6 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 24 Mar 2026, 16:05.

Change

Previous filing in this sequence was filed on 16 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001630864 Primary reporting owner

Duker Jay S.

Relationship: President and CEO, Director
Address: C/O EYEPOINT, INC., 480 PLEASANT STREET, SUITE C400, WATERTOWN
Signature: /s/ Ron Honig, Attorney-in-Fact
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EYPT transaction

Common Stock

Other

Transaction value
Shares: -76,766
Change %: -99%
Price: $13.11^*
Shares after: 986
Date: 23 Mar 2026
Ownership: Direct
Footnotes: F1

EYPT transaction

Common Stock

Other

Transaction value
Shares: +76,766
Change %: +76%
Price: $13.11^*
Shares after: 177,431
Date: 23 Mar 2026
Ownership: By Family Trust
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EYPT transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares: -52,500
Change %: -87%
Price: $8.75^*
Shares after: 7,800
Date: 23 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 52,500
Exercise price: $13.13
Footnotes: F1, F3

EYPT transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares: +52,500
Change %
Price: $8.75^*
Shares after: 52,500
Date: 23 Mar 2026
Ownership: By Family Trust
Underlying class: Common Stock
Underlying amount: 52,500
Exercise price: $13.13
Footnotes: F1, F2, F3

EYPT transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares: -97,500
Change %: -54%
Price: $9.57^*
Shares after: 82,500
Date: 23 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 97,500
Exercise price: $20.40
Footnotes: F1, F4

EYPT transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares: +97,500
Change %
Price: $9.57^*
Shares after: 97,500
Date: 23 Mar 2026
Ownership: By Family Trust
Underlying class: Common Stock
Underlying amount: 97,500
Exercise price: $20.40
Footnotes: F1, F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On March 23, 2026, the reporting person sold owned shares of ("Shares") and options to purchase ("Options") Common Stock of EyePoint, Inc. (the "Company") to the Duker Family 2024 Irrevocable Trust, (the "Family Trust"), in exchange for a promissory note in the principal amount of $2,398,220.93, representing the fair market value of the Shares and Options. For Shares, the fair market value was determined by utilizing the average of the high and low per share trading price on the date of the sale. For Options, the fair market value was determined using a Black Scholes model. The securities held in the Family Trust are for the benefit of the reporting person's children. The reporting person's spouse is a trustee of the Family Trust. The reporting person disclaims beneficial ownership of the security and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F2

These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F3

At the time of the sale, the portion of the options sold to the Family Trust and the remaining portion of the option retained by the reporting person was vested in full.

Footnote F4

The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the sale, the portion of the option that was sold to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 5, 2028.